Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Clinical Nuclear Medicine|May 21, 2024
225 Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177 Lu-PSMA-617 Radioligand Therapy : Pilot Experience From a Prospective RegistryFlorian Rosar, Caroline Burgard, Luna Vanessa Rohloff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2024
Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study)Florian Rosar, Joelle Schuler, Caroline Burgard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 24, 2019
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experienceFadi Khreish, Niklas Ebert, Martin Ries, et al.
Cancers|August 27, 2021
Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLTFadi Khreish, Kalle Ribbat, Mark Bartholomä, et al.
EJNMMI Physics|March 14, 2020
Image quality analysis of 44Sc on two preclinical PET scanners: a comparison to 68GaFlorian Rosar, Hans-Georg Buchholz, Sebastian Michels, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 13, 2025
Assessment of scintigraphic imaging with Terbium-161: A visual and quantitative analysisFlorian Rosar, Sven Petto, Sebastian Ganz, et al.
Cancers|March 11, 2023
Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center "Real-World" ExperienceCaroline Burgard, Manuela A Hoffmann, Madita Frei, et al.
EJNMMI Radiopharmacy and Chemistry|December 11, 2024
Development of a homotrimeric PSMA radioligand based on the NOTI chelating platformSebastian Martin, Moritz-Valentin Schreck, Tobias Stemler, et al.
Theranostics|March 20, 2024
[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617Andrea Schaefer-Schuler, Caroline Burgard, Arne Blickle, et al.
Cancers|March 25, 2022
Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA RelapseManuela A Hoffmann, Finn Edler von Eyben, Nicolas Fischer, et al.
Pageof 10